期刊文献+

浅谈药品生产企业在药品生产过程中的偏差管理 被引量:6

Discussion On the Management of Deviations in the Process of the Pharmaceutical Production by the Pharmaceutical Manufacturers
下载PDF
导出
摘要 目的阐述偏差的概念。方法药品生产企业质量管理部门应按照《药品GMP认证检查评定标准》的规定,制定和执行偏差处理程序,所有偏差应有记录,重大偏差应有调查报告。结果与结论提出我国药品生产企业在药品生产过程中出现偏差应如何进行处理的一些建议。 Objective To expatiate on the concept of deviation. Methods The department of quality management of the pharmaceutical manufacturers should be in accordance with the " Assessment Standards of GMP Certification Inspection", should develop and implement the procedures to deal with bias. All of errors should have been recorded, and the material deviation" should have an investigation report. Results and Conclutions To put forward some of the recommendations how Chinese pharmaceutical manufacturers should deal with the deviation in the process of the pharmaceutical production.
出处 《中国药事》 CAS 2009年第2期196-197,共2页 Chinese Pharmaceutical Affairs
关键词 药品生产 质量管理 偏差 pharmaceutical production quality management deviation
  • 相关文献

参考文献4

  • 1国家食品药品监督管理局.药品GMP认证检查评定标准[Z].国食药监安[2007]648号,2007.
  • 2药品生产质量管理规范[S].国家食品药品监督管理局令第7号,1998.
  • 3ICH (The International Conference on Harmaonization of Technical Requirements for Registration of Pharmaceuticals for Human Use) . Q7A (Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients) [Z] . 2001.
  • 4FDA (Food amd Drug Administration) . CGMP (Current Good Manufacturing Practice) [S] . 2005.

同被引文献32

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部